只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-08 2026-07-09 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen Director,Officer · PRESIDENT AND CEO | 卖出（S） | 888 | US$79.28 | US$70,397.09 | 768,815 | SEC |
| 2026-07-08 2026-07-09 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen Director,Officer · PRESIDENT AND CEO | 卖出（S） | 1,035 | US$80.19 | US$82,993.55 | 767,780 | SEC |
| 2026-07-01 2026-07-02 | HALO HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette Director | 卖出（S） | 1,000 | US$76.40 | US$76,395.00 | 42,669 | SEC |
| 2026-07-01 2026-07-02 | HALO HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette Director | 卖出（S） | 625 | US$77.21 | US$48,255.63 | 42,044 | SEC |
| 2026-06-29 2026-06-30 | HALO HALOZYME THERAPEUTICS, INC. | Krishnan Mahesh Director | 卖出（S） | 7,304 | US$75.00 | US$547,800.00 | 14,462 | SEC |
| 2026-06-03 2026-06-03 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen Director,Officer · PRESIDENT AND CEO | 卖出（S） | 6,100 | US$69.69 | US$425,109.00 | 767,780 | SEC |
| 2026-06-03 2026-06-03 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen Director,Officer · PRESIDENT AND CEO | 卖出（S） | 400 | US$66.37 | US$26,548.00 | 777,380 | SEC |
| 2026-06-03 2026-06-03 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen Director,Officer · PRESIDENT AND CEO | 卖出（S） | 1,500 | US$67.68 | US$101,520.00 | 775,880 | SEC |
| 2026-06-03 2026-06-03 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen Director,Officer · PRESIDENT AND CEO | 卖出（S） | 2,000 | US$68.74 | US$137,480.00 | 773,880 | SEC |
| 2026-06-02 2026-06-03 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen Director,Officer · PRESIDENT AND CEO | 卖出（S） | 3,400 | US$66.75 | US$226,950.00 | 767,780 | SEC |
| 2026-06-02 2026-06-03 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen Director,Officer · PRESIDENT AND CEO | 卖出（S） | 16,600 | US$66.31 | US$110.07万 | 771,180 | SEC |
| 2026-06-01 2026-06-03 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen Director,Officer · PRESIDENT AND CEO | 卖出（S） | 1,610 | US$66.39 | US$106,887.90 | 786,170 | SEC |
| 2026-06-01 2026-06-03 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen Director,Officer · PRESIDENT AND CEO | 卖出（S） | 12,989 | US$67.41 | US$875,588.49 | 773,181 | SEC |
| 2026-06-01 2026-06-03 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen Director,Officer · PRESIDENT AND CEO | 卖出（S） | 5,401 | US$68.35 | US$369,158.35 | 767,780 | SEC |
| 2026-06-01 2026-06-02 | HALO HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette Director | 卖出（S） | 1,625 | US$66.21 | US$107,591.25 | 43,669 | SEC |
| 2026-05-13 2026-05-13 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen Director,Officer · PRESIDENT AND CEO | 卖出（S） | 2,100 | US$68.10 | US$143,010.00 | 775,680 | SEC |
| 2026-05-13 2026-05-13 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen Director,Officer · PRESIDENT AND CEO | 卖出（S） | 3,350 | US$68.88 | US$230,748.00 | 772,330 | SEC |
| 2026-05-13 2026-05-13 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen Director,Officer · PRESIDENT AND CEO | 卖出（S） | 3,950 | US$69.79 | US$275,670.50 | 768,380 | SEC |
| 2026-05-13 2026-05-13 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen Director,Officer · PRESIDENT AND CEO | 卖出（S） | 600 | US$70.81 | US$42,486.00 | 767,780 | SEC |
| 2026-05-12 2026-05-13 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen Director,Officer · PRESIDENT AND CEO | 卖出（S） | 2,800 | US$73.12 | US$204,736.00 | 767,780 | SEC |
| 2026-05-12 2026-05-13 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen Director,Officer · PRESIDENT AND CEO | 卖出（S） | 100 | US$67.85 | US$6,785.00 | 787,680 | SEC |
| 2026-05-12 2026-05-13 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen Director,Officer · PRESIDENT AND CEO | 卖出（S） | 1,398 | US$70.29 | US$98,265.42 | 786,282 | SEC |
| 2026-05-12 2026-05-13 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen Director,Officer · PRESIDENT AND CEO | 卖出（S） | 9,802 | US$71.37 | US$699,568.74 | 776,480 | SEC |
| 2026-05-12 2026-05-13 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen Director,Officer · PRESIDENT AND CEO | 卖出（S） | 5,900 | US$72.15 | US$425,685.00 | 770,580 | SEC |
| 2026-05-11 2026-05-13 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen Director,Officer · PRESIDENT AND CEO | 卖出（S） | 9,725 | US$64.63 | US$628,526.75 | 778,055 | SEC |
| 2026-05-11 2026-05-13 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen Director,Officer · PRESIDENT AND CEO | 卖出（S） | 3,575 | US$65.46 | US$234,019.50 | 774,480 | SEC |
| 2026-05-11 2026-05-13 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen Director,Officer · PRESIDENT AND CEO | 卖出（S） | 6,700 | US$66.33 | US$444,411.00 | 767,780 | SEC |
| 2026-05-01 2026-05-05 | HALO HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette Director | 卖出（S） | 1,625 | US$63.48 | US$103,155.00 | 38,498 | SEC |
| 2026-04-09 2026-04-10 | EXOZ EXOZYMES INC. | Korman Tyler Paz Officer · Chief Scientific Officer | 卖出（S） | 750 | US$10.53 | US$7,897.50 | 729,123 | SEC |
| 2026-04-08 2026-04-10 | EXOZ EXOZYMES INC. | Korman Tyler Paz Officer · Chief Scientific Officer | 卖出（S） | 750 | US$10.04 | US$7,530.00 | 729,873 | SEC |
| 2026-04-06 2026-04-07 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen Director,Officer · PRESIDENT AND CEO | 卖出（S） | 5,900 | US$63.14 | US$372,526.00 | 771,880 | SEC |
| 2026-04-06 2026-04-07 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen Director,Officer · PRESIDENT AND CEO | 卖出（S） | 4,100 | US$64.02 | US$262,482.00 | 767,780 | SEC |
| 2026-04-02 2026-04-02 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen Director,Officer · PRESIDENT AND CEO | 卖出（S） | 4,200 | US$64.89 | US$272,538.00 | 767,780 | SEC |
| 2026-04-02 2026-04-02 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen Director,Officer · PRESIDENT AND CEO | 卖出（S） | 15,800 | US$64.06 | US$101.21万 | 771,980 | SEC |
| 2026-04-01 2026-04-02 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen Director,Officer · PRESIDENT AND CEO | 卖出（S） | 19,000 | US$65.36 | US$124.18万 | 768,780 | SEC |
| 2026-04-01 2026-04-02 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen Director,Officer · PRESIDENT AND CEO | 卖出（S） | 1,000 | US$65.71 | US$65,710.00 | 767,780 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| ZYME | 75,567.5169 | 0 | 118,047.4223 | 64.01% | B, Q, N |